Hospital
Second Hospital of Tianjin Medical University天津医科大学第二医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Published research 19 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 1 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan specialty reputation ranking
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| Urology 泌尿外科 | #10 | 2023 | Place in the specialty reputation ranking | https://www.fdygs.com/news2023-1.aspx |
Administrative grade
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| Grade as published Tier 3, class not published 三级(等次未标) | Tier 3, class not published | As of the end of December 2023 截至 2023 年 12 月底 | An administrative designation, not a ranking; the date is the list's own publication date, not the year the grade was awarded | The source of this record, at the foot of this page |
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 天津医科大学第二医院
- English name
- Second Hospital of Tianjin Medical University
- Grade
- Tier 3, class not published 三级(等次未标)
- Grade list as published
- As of the end of December 2023 截至 2023 年 12 月底
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Also known as
- The Second Hospital of Tianjin Medical University
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- QSOX1 confers ferroptosis resistance via redox modification of SLC7A11 in colorectal cancer. Cellular & molecular biology letters, 2026
- Integrative bulk and single-cell transcriptomics identify a recurrence-prognostic risk model with exploratory associations with treatment-response phenotypes in colorectal cancer. Human cell, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Urology #10 in the Fudan list.
-
Breast cancer
Published research
- EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer. Frontiers in pharmacology, 2026
- Differential distribution of microplastics in breast cancer and peritumoral tissues and relationship with clinical characteristics. Apoptosis : an international journal on programmed cell death, 2026
3 more published studies
PubMed indexes 5 papers on this condition that name this hospital.
Also ranked: Urology #10 in the Fudan list.
-
Lung cancer
Published research
- Analysis of risk factors and construction of a nomogram prediction model for early hemoptysis following (125)I seed implantation in patients with advanced lung cancer. Diagnostic and interventional radiology (Ankara, Turkey), 2026
- First-line versus second-line use of selpercatinib in treatment of RET fusion-positive advanced non-small cell lung cancer: a cost-effectiveness analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Urology #10 in the Fudan list.
-
Liver cancer
Published research
- Combination of exosome vaccines, lenvatinib, and anti-PD-1 eradicates tumor in autochthonous hepatocellular carcinoma mice. Cell reports. Medicine, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Urology #10 in the Fudan list.
-
Stomach cancer
Published research
- Correction: Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Urology #10 in the Fudan list.
-
Prostate cancer
Fudan specialty reputation ranking 2023
- Urology #10 https://www.fdygs.com/news2023-1.aspx
Published research
- PCAT1 Supports Partial AR-V7 Function and Promotes Enzalutamide Resistance in Prostate Cancer. International journal of general medicine, 2026
- Virtual screening and experimental validation of small-molecule compounds targeting AR in prostate cancer. Molecular diversity, 2026
6 more published studies
PubMed indexes 8 papers on this condition that name this hospital.
-
Bladder cancer
Fudan specialty reputation ranking 2023
- Urology #10 https://www.fdygs.com/news2023-1.aspx
-
Kidney cancer
Fudan specialty reputation ranking 2023
- Urology #10 https://www.fdygs.com/news2023-1.aspx
Other hospitals in Tianjin
Source & evidence
- Source URL
- https://www.fdygs.com/news2023-1.aspx
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24